Comment
ENS is a complex neural network that controls most of the gut functions by regulating motility, secretion/absorption and vascular tone. 2 The neurons and glia that comprise the ENS are derived from the migrating NC cells. 3 Many developmental and acquired disorders of ENS are characterized by loss of neurons. 4 One of the best-characterized enteric neuropathy is Hirschsprung's disease, which is caused by an absence of neurons in distal gastrointestinal tract. Surgical intervention is often the only treatment option for these disorders but is still plagued by postoperative morbidity. Replacement of the ENS has been considered a potential and futuristic treatment strategy. Stem cell transplantation is one such tool for replenishing the ENS. Furthermore, the authors demonstrated that Y27632 treatment increased the proportion of migrating NC-like cells derived from hESC in vitro. Y27632 is a ROCK I/II inhibitor, which selectively targets p160ROCK from the family of Rho-associated protein kinases. 7 Inhibition of Rho/ROCK signaling has been implicated in the epithelial-mesenchymal transition of NC cells from avian neural epithelium. 8 Epithelial-mesenchymal transition of neuroepithelial cells is the key step for neural tube formation and induction of the NC. The authors demonstrated that the hESC-derived NC-like cells behaved similarly to NC cells in avian embryos in that they assembled along NC migratory pathways and differentiated into neuronal (Hu, the generic neuronal marker positive) and glial cells (S100b positive) within the embryonic peripheral nervous system. This study also reports the integration of hESC-derived cells into the developing gut for the first time. However, further studies investigating the functional properties of the hESC-derived neurons are required before successful translation of this technique. Post transplant survival of cells in any cell-based therapy remains a big challenge and represents a critical limiting factor in successful repopulation. Tissue derived NC cells can be generated autologously and therefore cannot be immunerejected post transplantation leading to higher success rate. The authors discussed the potential of immunerejection of hESC-derived NC cells in transplantations since ESCs were not patient specific. They, however, suggested that patient specific induced pluripotent stem cells (iPSCs) might be able to fill this gap. 9 However, successful transfer of methodology developed in hESCs to iPSCs remains to be seen.
In conclusion, this study describes a simple and efficient method for generating NC-like cells from hESCs. These NC-like cells can potentially be a superior and unlimited source of cells for cell-based therapies of enteric neuropathies.
